Evaluation of Treatment Response in Patients with Breast Cancer

Saima Muzahir,Gary A Ulaner,David M Schuster
DOI: https://doi.org/10.1016/j.cpet.2023.04.007
Abstract:Breast cancer (BC) remains one of the leading causes of death among women. The management and outcome in BC are strongly influenced by a multidisciplinary approach, which includes available treatment options and different imaging modalities for accurate response assessment. Among breast imaging modalities, MR imaging is the modality of choice in evaluating response to neoadjuvant therapy, whereas F-18 Fluorodeoxyglucose positron emission tomography, conventional computed tomography (CT), and bone scan play a vital role in assessing response to therapy in metastatic BC. There is an unmet need for a standardized patient-centric approach to use different imaging methods for response assessment.
What problem does this paper attempt to address?